Literature DB >> 8689862

Impaired glucose tolerance--prevalence and conversion to NIDDM.

M I Harris1.   

Abstract

Impaired glucose tolerance (IGT) has been investigated in a large number of populations from different parts of the world and with differing lifestyles. The occurrence of IGT varies widely. IGT prevalence tends to increase with age, but there is no consistent relationship with gender. Prevalence is lower in groups with less obesity and having physically active lifestyles, such as those living in rural areas and having traditional lifestyles, even when subjects with the same genetic background are compared. Risk factors for IGT are similar to those for non-insulin dependent diabetes mellitus (NIDDM). IGT, characterized by hyperglycaemia and insulin resistance, is probably a stage in the pathogenesis of NIDDM. Therapies aimed at improving glucose tolerance and decreasing insulin resistance in subjects with IGT may, therefore, be able to delay or prevent the development of NIDDM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689862

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

Review 1.  Risk of diabetic nephropathy in potential living related kidney donors.

Authors:  D Simmons; M Searle
Journal:  BMJ       Date:  1998-03-14

2.  Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study.

Authors:  A W K Tso; P C Sham; N M S Wat; A Xu; B M Y Cheung; R Rong; C H Y Fong; J Y Xu; K K Y Cheng; E D Janus; K S L Lam
Journal:  Diabetologia       Date:  2006-06-21       Impact factor: 10.122

Review 3.  Preventing diabetes by treating aspects of the metabolic syndrome.

Authors:  Roopa Sathyaprakash; Robert R Henry
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

4.  Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus.

Authors:  Peter Emerson; Timon W Van Haeften; Walkyria Pimenta; Elena Plummer; Hans J Woerle; Asimina Mitrakou; Ervin Szoke; John Gerich; Christian Meyer
Journal:  Metabolism       Date:  2009-05       Impact factor: 8.694

5.  Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China.

Authors:  Chang-Yu Pan; Harald Landen
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

6.  Chronic treatment with the thiazolidinedione, MCC-555, is associated with reductions in nitric oxide synthase activity and beta-cell apoptosis in the pancreas of the Zucker Diabetic Fatty rat.

Authors:  Lucy C Pickavance; Peter S Widdowson; John R Foster; Gareth Williams; John P H Wilding
Journal:  Int J Exp Pathol       Date:  2003-04       Impact factor: 1.925

7.  Prevalence of abnormal glucose tolerance and risk factors in urban and rural Malaysia.

Authors:  Norlaila Mustafa; Nor Azmi Kamarudin; Ab Aziz Ismail; Amir Sharifuddin Khir; Ikram Shah Ismail; Kamarul Imran Musa; Khalid Abdul Kadir; Nor Azwany Yaacob; Osman Ali; Siti Harnida Md Isa; Wan Mohamad Wan Bebakar; Wan Nazaimoon wan Mohamud
Journal:  Diabetes Care       Date:  2011-04-15       Impact factor: 19.112

8.  High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population.

Authors:  Timo E Saaristo; Noël C Barengo; Eeva Korpi-Hyövälti; Heikki Oksa; Hannu Puolijoki; Juha T Saltevo; Mauno Vanhala; Jouko Sundvall; Liisa Saarikoski; Markku Peltonen; Jaakko Tuomilehto
Journal:  BMC Public Health       Date:  2008-12-29       Impact factor: 3.295

9.  Reduced progression to type 2 diabetes from impaired glucose tolerance after a 2-day in-hospital diabetes educational program: the Joetsu Diabetes Prevention Trial.

Authors:  Tetsuya Kawahara; Keiichi Takahashi; Tetsuya Inazu; Tadashi Arao; Chie Kawahara; Takahiro Tabata; Hiroyuki Moriyama; Yosuke Okada; Emiko Morita; Yoshiya Tanaka
Journal:  Diabetes Care       Date:  2008-06-30       Impact factor: 17.152

10.  Retrospective study on the efficacy of a low-carbohydrate diet for impaired glucose tolerance.

Authors:  Satoshi Maekawa; Tetsuya Kawahara; Ryosuke Nomura; Takayuki Murase; Yasuyoshi Ann; Masayuki Oeholm; Masaru Harada
Journal:  Diabetes Metab Syndr Obes       Date:  2014-06-13       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.